BALCHEM CORP
BCPCNasdaq
$163.35
↓ -1.7%Jul 17 close · end-of-day
Price
1Y↑ +7.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$5.3B
Enterprise Value
$5.2B
P/E
33.5
P/S
5.0
P/B
4.1
EV/EBITDA
19.9
PEG
2.5
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$1.1B
Net Income (TTM)
$158.1M
Free Cash Flow (TTM)
—
Gross Margin
36.3%
Operating Margin
20.2%
Net Margin
14.9%
ROE
12.3%
ROIC
13.7%
Debt / Equity
—
Net Cash
$72.9M
Return 1Y
+7.2%
Company profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates through three segments: Human Nutrition, Animal Nutrition & Health, and Specialty Products. The company sells its products through sales force, independent distributors, and sales agents.
- CEO
- Theodore L. Harris
- Sector
- Manufacturing
- Industry
- Chemicals
- Employees
- 1,340
- Headquarters
- New Jersey
- Website
- balchem.com
Management & directors
- Backus William A.VP & Chief Accounting Officer
- Bengtsson Carl MartinEVP & Chief Financial Officer
- Boned FredericSVP/GM, Human Nutri. & Health
- Harris Theodore LChairman, President & CEO
- Miyata HatsukiEVP, CLO, & Secretary
- Reid Martin LutherSVP Chief Supply Chain Officer
- Tignor Michael BrentSVP & Chief HR Officer
- Van Gunsteren Job LeonardSVP and GM, Specialty Products
- Graham GeorgeSVP and Chief R&D Officer
Roles derived from SEC Form 4 filings.
Earnings
BCPC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$270.7M↑ +8.1%
Diluted EPS$1.25↑ +10.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $703.6M | $799.0M | $942.4M | $922.4M | $953.7M | $1.0B |
| Gross profit | $223.9M | $243.2M | $280.5M | $302.1M | $336.2M | $370.6M |
| Operating income | $111.1M | $127.5M | $145.2M | $159.2M | $182.9M | $209.3M |
| Net income | $84.6M | $96.1M | $105.4M | $108.5M | $128.5M | $154.8M |
| Diluted EPS | $2.60 | $2.94 | $3.25 | $3.35 | $3.93 | $4.75 |
| Operating cash flow | $150.5M | $160.5M | $138.5M | $183.8M | $182.0M | $216.6M |
| Free cash flow | $118.4M | $124.4M | $89.5M | — | — | — |
| Gross margin | 31.8% | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% |
| Operating margin | 15.8% | 16.0% | 15.4% | 17.3% | 19.2% | 20.2% |
| Net margin | 12.0% | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $234.1M | $239.9M | $240.0M | $250.5M | $255.5M | $267.6M | $263.6M | $270.7M |
| Gross profit | $83.0M | $85.4M | $86.3M | $88.2M | $93.1M | $95.5M | $93.9M | $101.1M |
| Operating income | $45.8M | $48.0M | $47.4M | $51.0M | $51.4M | $54.6M | $52.3M | $55.6M |
| Net income | $32.1M | $33.8M | $33.6M | $37.1M | $38.3M | $40.3M | $39.2M | $40.3M |
| Diluted EPS | $0.98 | $1.03 | $1.03 | $1.13 | $1.17 | $1.24 | $1.21 | $1.25 |
| Operating cash flow | $45.0M | $51.3M | $52.3M | $36.5M | $47.3M | $65.6M | $67.3M | $40.1M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 35.5% | 35.6% | 36.0% | 35.2% | 36.4% | 35.7% | 35.6% | 37.3% |
| Operating margin | 19.6% | 20.0% | 19.8% | 20.4% | 20.1% | 20.4% | 19.8% | 20.5% |
| Net margin | 13.7% | 14.1% | 14.0% | 14.8% | 15.0% | 15.1% | 14.9% | 14.9% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-02-12 | Harris Theodore L· Chairman, President & CEO | Tax withholding | 844 | $177.49 | $149,801.56 | filing |
| 2026-02-12 | Bengtsson Carl Martin· EVP & Chief Financial Officer | Tax withholding | 302 | $177.49 | $53,601.98 | filing |
| 2026-02-12 | Boned Frederic· SVP/GM, Human Nutri. & Health | Tax withholding | 203 | $177.49 | $36,030.47 | filing |
| 2026-02-12 | Miyata Hatsuki· EVP, CLO, & Secretary | Tax withholding | 181 | $177.49 | $32,125.69 | filing |
| 2026-02-12 | Tignor Michael Brent· SVP & Chief HR Officer | Tax withholding | 165 | $177.49 | $29,285.85 | filing |
| 2026-02-12 | Reid Martin Luther· SVP Chief Supply Chain Officer | Tax withholding | 116 | $177.49 | $20,588.84 | filing |
| 2026-02-12 | Backus William A.· VP & Chief Accounting Officer | Tax withholding | 70 | $177.49 | $12,424.30 | filing |
| 2026-02-12 | van Gunsteren Job Leonard· SVP and GM, Specialty Products | Tax withholding | 58 | $177.49 | $10,294.42 | filing |
| 2026-02-11 | Harris Theodore L· Chairman, President & CEO | Tax withholding | 9,358 | $178.68 | $1.7M | filing |
| 2026-02-11 | Bengtsson Carl Martin· EVP & Chief Financial Officer | Tax withholding | 2,416 | $178.68 | $431,690.88 | filing |
| 2026-02-11 | Boned Frederic· SVP/GM, Human Nutri. & Health | Tax withholding | 1,151 | $178.68 | $205,660.68 | filing |
| 2026-02-11 | Reid Martin Luther· SVP Chief Supply Chain Officer | Tax withholding | 1,085 | $178.68 | $193,867.80 | filing |
| 2026-02-11 | Tignor Michael Brent· SVP & Chief HR Officer | Tax withholding | 991 | $178.68 | $177,071.88 | filing |
| 2026-02-11 | Miyata Hatsuki· EVP, CLO, & Secretary | Tax withholding | 877 | $178.68 | $156,702.36 | filing |
| 2026-02-11 | Backus William A.· VP & Chief Accounting Officer | Tax withholding | 865 | $178.68 | $154,558.20 | filing |
| 2026-02-11 | van Gunsteren Job Leonard· SVP and GM, Specialty Products | Tax withholding | 756 | $178.68 | $135,082.08 | filing |
| 2026-02-11 | Bengtsson Carl Martin· EVP & Chief Financial Officer | Award | 3,610 | $0.00 | $0.00 | filing |
| 2026-02-11 | Bengtsson Carl Martin· EVP & Chief Financial Officer | Award | 4,718 | $0.00 | $0.00 | filing |
| 2026-02-11 | Rigaud Olivier | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | Knutson Daniel E | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | Fish Kathleen B | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | Wineinger Matthew David | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | Fischer David B | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | VICENTE MONICA | Award | 870 | $0.00 | $0.00 | filing |
| 2026-02-11 | van Gunsteren Job Leonard· SVP and GM, Specialty Products | Award | 430 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.